Growth hormone (GH) therapy is a very promising intervention for preventing and treating dementia and early-stage Alzheimer's disease, and it contributes significantly to the recovery of brain function in patients after traumatic injury and stroke. This evidence concerns the gene GH1 and early-onset autosomal dominant Alzheimer disease.